Loading...
Market
First company to announce new COVID-19 vaccine for seniors by end of 2024?
3
Resolution / Starting Odds
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Official announcements from pharmaceutical companies
Story
CDC Recommends Twice Yearly Second COVID Vaccine Dose for Seniors, Immunocompromised for 2024-2025
Oct 23, 2024, 10:04 PM
The Centers for Disease Control and Prevention (CDC) is set to recommend a second COVID-19 vaccine dose for individuals aged 65 and older and for those with moderate to severe immunocompromising conditions. This recommendation, which is part of a new policy for the 2024-2025 period, suggests a vaccination cadence of every six months. The advisory group made these recommendations to enhance protection among vulnerable populations and provide clearer guidance for patients and healthcare providers. The CDC's decision is seen as a significant step to safeguard older adults and those with compromised immune systems.
View original story
Similar markets
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Sanofi • 25%
Other • 25%
Company X • 25%
Company Y • 25%
Company Z • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
GSK • 33%
Sanofi • 33%
Seqirus • 33%
WHO • 25%
CDC • 25%
European Medicines Agency (EMA) • 25%
Other • 25%
GSK • 25%
Sanofi • 25%
CSL • 25%
None by deadline • 25%